A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT07379424 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

COMBINATION_PRODUCT: Adjuvant therapy: sintilimab combined with radiotherapy

Sponsor

chen chao Professor